简体中文 | 繁體中文 | English

Brightree

Brightree Acquires Mobile Delivery Provider Apacheta to Streamline HME Delivery

Brightree to innovate and expand adoption of Apacheta’s mobile delivery solution to more HME customers

2018-12-18 18:49
  • zh_cn
  • zh_hant
  • en

ATLANTA--()--Brightree, a leading provider of cloud-based software helping out-of-hospital providers improve business performance and patient outcomes, today announced it has acquired privately held mobile delivery and cloud-based software-as-a-service (SaaS) provider Apacheta Corporation, further expanding the SaaS portfolio of Brightree’s owner, ResMed.

The terms of the transaction were not disclosed.

Apacheta offers mobile applications that empower companies to automate and streamline business processes in route sales, field marketing, pick-up and delivery, transportation and field services.

Apacheta and its Media, PA-based employees will join Brightree, whose platform it has been integrated with since 2015. A secure mobile delivery module for ordering and tracking medical equipment was the number one feature request of HMEs in a recent customer satisfaction survey. Brightree will guide the further innovation of Apacheta’s solution and help increase adoption among Brightree customers.

“Apacheta solves many of the business challenges HMEs face in managing deliveries, particularly eliminating missing, lost or incomplete delivery information,” said Brightree CEO Matt Mellott. “It has already helped Brightree customers save significant time and money, and we look forward to investing in its continued innovation and scalability.”

“We’re thrilled to become part of a healthcare leader that shares our mission: leveraging technology to digitally transform field service management and delivery functions providing quantifiable business efficiencies, better customer care, and improved visibility to logistics practices,” said Apacheta CEO Gregg Timmons.

“The HME business is becoming more and more challenging, and like Apacheta, Brightree offers software solutions that eliminate complexity in order to increase productivity,” Timmons said. “The entire Apacheta team and I look forward to becoming part of the Brightree/ResMed family.”

Apacheta is Brightree’s third acquisition in the past 18 months, following Conduit Technology, which enhances HMEs’ custom forms and workflow solutions, and AllCall Connect, providing live call center services. Both of these additions strengthen Brightree’s offerings to HMEs, while ResMed evaluates where else they may be integrated within its larger SaaS ecosystem.

“Adding a reliable market-tested mobile delivery platform to ResMed’s SaaS portfolio helps our customers work more seamlessly and provide a better experience for their patients,” said ResMed SaaS President Raj Sodhi. “In addition to driving further innovation of this platform, we will explore bringing this solution to other care settings and platforms that would benefit by having a mobile delivery solution.”

About Brightree

Brightree LLC, a wholly owned subsidiary of ResMed (NYSE: RMD, ASX: RMD), is the leading provider of cloud-based software to improve clinical and business performance of post-acute care companies. Ranked one of the top 100 healthcare IT companies in the U.S., Brightree serves more than 2,200 organization in the HME, home health, hospice, orthotic and prosthetic, HME pharmacy, home infusion, and rehabilitation home care segments. For more information, visit www.brightree.com or call 1.888.598.7797.

About Apacheta

Apacheta Corporation provides a mobile delivery management solution designed to enable post-acute care equipment providers to automate and streamline delivery operations that ultimately improve patient outcomes. The company’s workflow management platform and mobile applications enable organizations to manage the delivery process by creating a paperless environment that increases fiscal efficacy and field force productivity. For more information, visit www.apacheta.com.

Contacts

For media:
Jayme Rubenstein, 858.836.6798, news@resmed.com

For investors:
Amy Wakeham, 858.836.5000, investorrelations@resmed.com